Literature DB >> 24821093

GM1 ganglioside enhances Ret signaling in striatum.

Erin N Newburn1, Anne-Marie Duchemin, Norton H Neff, Maria Hadjiconstantinou.   

Abstract

It has been proposed that GM1 ganglioside promotes neuronal growth, phenotypic expression, and survival by modulating tyrosine kinase receptors for neurotrophic factors. Our studies tested the hypothesis that GM1 exerts its neurotrophic action on dopaminergic neurons, in part, by interacting with the GDNF (glia cell-derived neurotrophic factor) receptor complex, Ret tyrosine kinase and GFRα1 co-receptor. GM1 addition to striatal slices in situ increased Ret activity in a concentration- and time-dependent manner. GM1-induced Ret activation required the whole GM1 molecule and was inhibited by the kinase inhibitors PP2 and PP1. Ret activation was followed by Tyr1062 phosphorylation and PI3 kinase/Akt recruitment. The Src kinase was associated with Ret and GM1 enhanced its phosphorylation. GM1 responses required the presence of GFRα1, and there was a GM1 concentration-dependent increase in the binding of endogenous GDNF which paralleled that of Ret activation. Neutralization of the released GDNF did not influence the Ret response to GM1, and GM1 had no effect on GDNF release. Our in situ studies suggest that GM1 via GFRα1 modulates Ret activation and phosphorylation in the striatum and provide a putative mechanism for its effects on dopaminergic neurons. Indeed, chronic GM1 treatment enhanced Ret activity and phosphorylation in the striatum of the MPTP-mouse and kinase activation was associated with recovery of dopamine and DOPAC deficits. It has been proposed that the ganglioside GM1 promotes neuronal growth, phenotypic expression, and survival by modulating tyrosine kinase receptors for neurotrophic factors. We provide evidence that the GM1 enhances the activity of Ret tyrosine kinase receptor for glia cell-derived neurotrophic factor (GDNF) in the striatum in situ and in vivo, and propose that this might be a mechanism for GM1's neurotrophic actions on dopaminergic neurons. Ret activation is followed by Tyr1062 and Tyr981 phosphorylation and recruitment of PI3-K/Akt, Erk, and Src signaling. GM1 apparently acts by increasing the binding of endogenous GDNF to GFRα1 co-receptor, which is required for the GM1 effect on Ret.
© 2014 International Society for Neurochemistry.

Entities:  

Keywords:  GDNF; GFRα1; GM1; PI3 kinase; Ret; Src

Mesh:

Substances:

Year:  2014        PMID: 24821093     DOI: 10.1111/jnc.12760

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

Authors:  Y Akkhawattanangkul; P Maiti; Y Xue; D Aryal; W C Wetsel; D Hamilton; S C Fowler; M P McDonald
Journal:  Genes Brain Behav       Date:  2017-04-18       Impact factor: 3.449

Review 2.  GM1 Ganglioside: Past Studies and Future Potential.

Authors:  Massimo Aureli; Laura Mauri; Maria Grazia Ciampa; Alessandro Prinetti; Gino Toffano; Cynthia Secchieri; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2015-03-12       Impact factor: 5.590

3.  A role for Galgt1 in skeletal muscle regeneration.

Authors:  Neha Singhal; Paul T Martin
Journal:  Skelet Muscle       Date:  2015-01-27       Impact factor: 4.912

Review 4.  Gangliosides: Treatment Avenues in Neurodegenerative Disease.

Authors:  Pierre J Magistretti; Fred H Geisler; Jay S Schneider; P Andy Li; Hubert Fiumelli; Simonetta Sipione
Journal:  Front Neurol       Date:  2019-08-06       Impact factor: 4.003

Review 5.  GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration.

Authors:  Elena Chiricozzi; Giulia Lunghi; Erika Di Biase; Maria Fazzari; Sandro Sonnino; Laura Mauri
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

Review 6.  Interplay of BDNF and GDNF in the Mature Spinal Somatosensory System and Its Potential Therapeutic Relevance.

Authors:  Francesco Ferrini; Chiara Salio; Elena M Boggio; Adalberto Merighi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 7.  GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease.

Authors:  Xavier d'Anglemont de Tassigny; Alberto Pascual; José López-Barneo
Journal:  Front Neuroanat       Date:  2015-02-13       Impact factor: 3.856

Review 8.  Metabolism of Glycosphingolipids and Their Role in the Pathophysiology of Lysosomal Storage Disorders.

Authors:  Alex E Ryckman; Inka Brockhausen; Jagdeep S Walia
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

Review 9.  The structure of gangliosides hides a code for determining neuronal functions.

Authors:  Giulia Lunghi; Maria Fazzari; Erika Di Biase; Laura Mauri; Elena Chiricozzi; Sandro Sonnino
Journal:  FEBS Open Bio       Date:  2021-06-15       Impact factor: 2.693

Review 10.  Novel insights on GM1 and Parkinson's disease: A critical review.

Authors:  Maria Fazzari; Erika Di Biase; Giulia Lunghi; Laura Mauri; Elena Chiricozzi; Sandro Sonnino
Journal:  Glycoconj J       Date:  2022-01-22       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.